Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03545282 · ClinicalTrials.gov registry record · NA
Intervention Trial to Reduce Mental Health Disparities in Latina Immigrant Women
A NA study of Depression and Anxiety, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 226
- Enrollment target
- 2
- Study locations
NCT03545282: Completed NA study of Depression and Anxiety, sponsored by University of Washington.
NCT03545282 is a NA study of Depression and Anxiety that has completed, run by University of Washington. The registered enrollment target is 226 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03545282, a NA study of Depression and Anxiety, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 226 participants
- Enrollment target
- 2
- Study locations
Study Summary
Latina immigrant women are particularly vulnerable to depression and anxiety due to the social and economic stressors they face, including high levels of poverty, low levels of education, family obligations, exposure to violence, and limited access to community resources. ALMA aims to prevent and reduce depression and anxiety among Latina immigrant women. Women attend 8 weekly sessions in a group format to teach and encourage women to use coping strategies to reduce depression and anxiety. The intervention aims to increase participants' social ties and the social support they receive from other Latina immigrant women. The program also helps decrease the stigma associated with mental health and connects women to mental health services when needed.
Primary Outcome
Frequency of depressive symptoms as measured by the Patient Health Questionnaire 9 in the last two weeks. The PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression. Scores range from 0 to 27. In general, a total of 10 or above is suggestive of the presence of depression. Depression Severity: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe. Higher scores indicate a worse outcome.
Conditions Studied
Interventions
- BEHAVIORAL Amigas Latinas Motivando el Alma (ALMA)
Study Locations (2)
Washington
- Casa Latina - Seattle
- El Centro de la Raza - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2018-09-26 |
| Est. Completion | 2022-01-01 |
| Phase | NA |
What the finished NCT03545282 record still lists
NCT03545282 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (71% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Amigas Latinas Motivando el Alma (ALMA) is the first listed.
NCT03545282 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT03545282 about?
NCT03545282 is a clinical study titled "Intervention Trial to Reduce Mental Health Disparities in Latina Immigrant Women". Latina immigrant women are particularly vulnerable to depression and anxiety due to the social and economic stressors they face, including high levels of poverty, low levels of education, family obligations, exposure to violence, and limited access to community resources. ALMA aims to prevent and re...
What is the current status of trial NCT03545282?
This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2018-09-26. Estimated completion is 2022-01-01.
What conditions does trial NCT03545282 study?
This clinical trial studies the following conditions: Depression, Anxiety, Stress.
What interventions are being tested in trial NCT03545282?
The interventions under investigation include: Amigas Latinas Motivando el Alma (ALMA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03545282?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03545282 being conducted?
This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03545282's enrollment target sits among peer trials
226 192nd of 679 higher than 486 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04419272 · 226 participants · Phase 4
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- NCT05488054 · 226 participants · NA
Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery
- NCT05924477 · 226 participants · NA
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
- NCT06106945 · 226 participants · Phase 1
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy